Cortexyme, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Cortexyme, Inc.
CIK #0001662774
EDGAR Form CIK 2011 - 2025
10-K [0001662774]
10-Q [0001662774]
3 [0001662774]
4 [0001662774]
5 [0001662774]
8-K [0001662774]
D [0001662774]
SC 13D [0001662774]
SC 13G [0001662774]
Form 13D/13G Filer Form 13D/13G Subject Filed
Nantahala Capital Management LLC Quince Therapeutics Inc [2025-08-14]
Sofinnova Partners SAS Quince Therapeutics Inc [2025-02-14]
Lamond David Quince Therapeutics Inc [2024-11-13]
Sofinnova Partners SAS Quince Therapeutics Inc [2024-02-12]
Genextra Spa Quince Therapeutics Inc [2023-12-15]
BML Investment Partners LP Quince Therapeutics Inc [2023-07-17]
Tang Capital Partners LP Quince Therapeutics Inc [2023-03-31]
Capital World Investors Cortexyme Inc [2021-02-16]
Capital International Investors Cortexyme Inc [2021-02-16]
Capital International Investors Cortexyme Inc [2021-02-16]
View All
Form 3/4/5 Subject 2011 - 2025
Hannah Brendan
Quince Therapeutics, Inc.
Ryan Charles S.
Thye Dirk
Lamond David
Senner Christopher J.
Benatti Luca
Ryan UNA S
Patni Rajiv
Bray June
McLoughlin Margaret
Janhofer Guenter
Monohon Ted
Smith Karen L.
McDowell Caryn Gordon
Holsinger Leslie
Low Philip S
Sabbagh Marwan
Detke Michael J.
Lowe Christopher P
Dominy Stephen S.
Lynch Casey
Boeding Chad
EPIQ Capital Group, LLC
Young Kevin
Pfizer Inc
Pfizer Strategic Investment Holdings LLC
Pfizer Ventures (US) LLC
Gafric Kristen
Takeda Ventures, Inc.
Takeda Pharmaceuticals International AG
Takeda Pharmaceutical Co Ltd
Takeda Pharmaceuticals U.S.A., Inc.
Lamond Pierre
Lamond Christine
Terms | Privacy | Guide
tony@aum13f.com